Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer
Charles E. Geyer, MD, FACP, discusses dosing strategies and adverse event management with olaparib.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries
Telephone and Web-Based Program Elicits Clinically Meaningful Results in Breast Cancer Survivors
Luspatercept Elicits High Transfusion Independence Rates in Lower-Risk MDS
